Genialis
PrivateLast Round
Series A
Mar 29, 2023
Total Funding Raised
$15.3M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Genialis operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Series A round in March 2023.
Genialis is a precision oncology company that develops clinically actionable RNA-based biomarkers using artificial intelligence and machine learning to predict patient responses to therapies.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genialis Comparables
Compare Genialis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pangea Biomed | 83% | |
| Betteromics | 82% | |
| Elucidata | 82% |
For institutional investors. Book with your work email.
Genialis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 29, 2023 | ||||
| Grant | Oct 14, 2021 | ||||
| Seed | Nov 13, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Genialis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Taiwania Capital | Series A |
| P5 Health Ventures | Series A |
| First Star Ventures | Series A, Seed |
| Redalpine | Series A, Seed |
| Pikas | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors increased 53% MoM, reaching 4.2K.
- Oct 2, 2025
AI-powered biomarkers for pancreatic cancer in collaboration with Cleveland Clinic.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventOct 23, 2026
Genialis is to present data at the European Society for Medical Oncology (ESMO) Congress 2026 showing that its biology-first models predict treatment response with limited patient data.
- integrates_withSep 24, 2026
Genialis will integrate its Supermodel with Inventia Life Science Pty Ltd.'s RASTRUM 3D cell model platform to study pancreatic ductal adenocarcinoma and test therapeutic hypotheses.
- partners_withSep 24, 2026
Genialis and Pancreatic Cancer Action Network, Inc. have a long-standing collaboration that generated data used to identify poor-prognosis pancreatic cancer patients, with related research presented in California on Sep 25th '26.
For institutional investors. Book with your work email.
Genialis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Genialis's valuation, stock price, and market status.
Is Genialis a public or private company?
Genialis is a private company.
What is the current stock price of Genialis?
Genialis is a private company, so its shares have no public market price. Caplight tracks Genialis's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Genialis worth (valuation)?
Valuation information for Genialis is not publicly available.
Can I buy Genialis stock?
Genialis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Genialis's last funding round?
Genialis's most recent funding round was Series A on March 29, 2023.
Who are the main investors in Genialis?
Key investors in Genialis include Taiwania Capital, First Star Ventures, Redalpine.
Will Genialis IPO soon?
No public IPO plans have been announced for Genialis.
How can I track Genialis secondary market activity?
Caplight tracks bids, offers, and trades in Genialis's shares on secondary markets.